Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, physical- and occupational-therapy clinic operator U.S. Physical Therapy (NAS: USPH) has earned a coveted five-star ranking.
With that in mind, let's take a closer look at U.S. Physical Therapy and see what CAPS investors are saying about the stock right now.
U.S. Physical Therapy facts
CEO Christopher Reading (since 2004)
Return on Equity (Average, Past 3 Years)
$10.0 million / $24.2 million
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 98% of the 236 members who have rated U.S. Physical Therapy believe the stock will outperform the S&P 500 going forward.
Physical therapy is of growing importance across the population, and as active Baby Boomers begin to retire they will have more time for both exercise and therapy.
[U.S. Physical Therapy] has grown revenue at least nine straight years. ... Valuation looks good too.
If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite a strong five-star rating, U.S. Physical Therapy may not be your top choice.
We've found another stock we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2012." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so access it now.
Want to see how well (or not so well) the stocks in this series are performing? Follow the newTrackPoisedToCAPS account.
At the time thisarticle was published Fool contributorBrian Pacamparaowns no position in any of the companies mentioned. Try any of our Foolish newsletter servicesfree for 30 days. We Fools don't all hold the same opinions, but we all believe thatconsidering a diverse range of insightsmakes us better investors. The Fool'sdisclosure policyalways gets a perfect score.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.